Erythropoietin Beta
B03X - Other antianemic preparations
ATC B03XA01
JFDA label: Recormon PFS
Chemistry & Properties
| Formula | C42H73NO16 |
|---|---|
| Molecular weight | 848.0 g/mol |
| IUPAC name | (4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4R,5S,6R)-5-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-7-(2-hydroxyethyl)-5-methoxy-9,16-dimethyl-1-oxacyclohexadeca-11,13-dien-2-one |
| CAS | 113427-24-0 |
| PubChem CID | 92043599 |
| InChIKey | CJKGNDLRMLFWEX-IUJNAFBCSA-N |
| logP | 0.8 (XLogP 0.8) |
| Polar surface area | 236.0 Ų |
| H-bond acceptors / donors | 17 / 7 |
SMILES
CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CCO)C)OC4CC(C(C(O4)C)O)(C)OBiology & Pharmacokinetics
Pharmacokinetics predicted
| Bioavailability | 70.0% |
|---|---|
| Half-life | 5.786 h |
| Volume of distribution | 0.784 L/kg |
| Protein binding | 49.3% |
| BBB penetrant | No |
Enzyme interactions
| Enzyme | Role | Detail |
|---|---|---|
| CYP2C19 | Substrate | — |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (5)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
|---|---|---|---|---|
| RECORMON VIAL | Vial 5000 IU | 5 +5 SOLV. | Shawi & Rushedat Drug Store | — |
| Recormon PFS | Pre-filled Syringe 5000 IU/0.3 ml | 6 | Shawi & Rushedat Drug Store | — |
| Recormon PFS | Pre-filled Syringe 2000 IU/0.3 ml | 6 PFS | Shawi & Rushedat Drug Store | — |
| Recormon PFS | Pre-filled Syringe 6000 IU/0.3 ml | 6 | Shawi & Rushedat Drug Store | — |
| Recormon PFS | Pre-filled Syringe 30000 IU/0.6 ml | 4 PFS | Shawi & Rushedat Drug Store | — |